Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1136studies shown
Showing 961-972 of 1,136
Device study icon
CompletedNCT01880255

rTMS for Working Memory Deficits in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 59 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
Device study icon
CompletedNCT01806168

rTMS in the Treatment of PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
PTSDDeviceFrom 19 Years to 70 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
PTSD
Device study icon
CompletedNCT00616486

rTMS in Treatment of OCD (OCD)

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
OCDDeviceFrom 18 Years to 65 Years
Countries
Canada, Bulgaria, Türkiye
Sponsor
Queen's University
Condition
OCD
Device study icon
WithdrawnNCT02450695

rTMS in Treatment Refractory OCD

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
OCDDeviceFrom 18 Years to 65 Years
Countries
Canada
Sponsor
McMaster University
Condition
OCD
Device study icon
TerminatedNCT03069612

rTMS Treatment for Cannabis Use Disorders in Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Canada
Schizophrenia, AddictionDeviceFrom 16 Years to 35 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia, Addiction
Drug study icon
WithdrawnNCT00359125

RU-486 in the Treatment of Depression in bipolarity

This study exists to learn from real-world information that can show how the medication RU-486 fits into care. Researchers are trying to understand whether the medication RU-486 can improve attention, thinking, or day-to-day functioning.

In Canada
Bipolarity, DepressionDrugA study involving a medication or substance.From 19 Years to 65 Years
Countries
Canada
Sponsor
University of British Columbia
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01922258

Flexible Dosing of Brexpiprazole for Mental health

This study is completed in the United States, in France, in Canada, .... It is testing flexible Dosing of Brexpiprazole for Mental health.

In Canada
Mental healthDrugFrom 55 Years to 90 Years
Countries
United States, France, Canada, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Mental health
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.